Researchers say integrated multi-'omic' studies could accelerate the use of precision medicine for asthma patients.
List view / Grid view
Filter the results
Researchers have developed a stabilisation technique for widespread viruses, creating drug opportunity.
Treatments for chronic inflammatory diseases are one step closer as a new study discovers a way to stop inflammation in its tracks.
Contrary to previous notions that the receptor dectin-1 causes allergic reactions, new research from the John Hopkins Bloomberg School of Public Health has found that it actually prevents this response, indicating new targets for allergy and asthma drugs.
Blocking the action of two pro-inflammatory molecules can significantly reduce the symptoms of allergic asthma...
SMi’s 13th annual Asthma & COPD conference returns to London on the 29 and 30 March 2017...
MRC Technology, AstraZeneca, Asthma UK and British Lung Foundation to collaborate on respiratory disease research
1 September 2016 | By Niamh Louise Marriott, Digital Content Producer
A collaboration to investigate the link between epigenetics and respiratory disease and to find new drug treatments involves...
15 June 2016 | By Victoria White, Digital Content Producer
MRCT and AstraZeneca are seeking academics with relevant epigenetics targets to collaborate with them to develop novel treatments for respiratory diseases...